Terms: = Leukemia AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
825 results:
1. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
2. Demographic Disparities in Acute Myeloid leukemia Mortality Trends in the United States.
Doddi S; Salichs O; Hibshman T; Alamir P; Kunte S
Anticancer Res; 2024 May; 44(5):2211-2217. PubMed ID: 38677760
[TBL] [Abstract] [Full Text] [Related]
3. Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study.
Urgessa F; Lengiso B; Tsegaye A; Gebremedhin A; Abdella F; Tadesse F; Radich J; Nigussie H; Kuru Gerbaba T
BMC Cancer; 2024 Apr; 24(1):530. PubMed ID: 38664756
[TBL] [Abstract] [Full Text] [Related]
4. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
[TBL] [Abstract] [Full Text] [Related]
5. Interaction of olive oil-based propolis and caffeic acid phenethyl ester with methylprednisolone used in the treatment of human acute myeloid leukemia.
Dogan H; Ozcimen AA; Silici S
Mol Biol Rep; 2024 Apr; 51(1):559. PubMed ID: 38643306
[TBL] [Abstract] [Full Text] [Related]
6. Epidemiological characteristics and influencing factors of acute leukemia in children and adolescents and adults: a large population-based study.
Liu S; Hu B; Zhang J
Hematology; 2024 Dec; 29(1):2327916. PubMed ID: 38578123
[TBL] [Abstract] [Full Text] [Related]
7. Trend Analysis of leukemia Mortality and Years of Life Lost (YLL) from 2004 to 2019 in the Fars Province, Iran.
Azarbakhsh H; Rezaei F; Hassanzadeh J; Dehghani SP; Janfada M; Mirahmadizadeh A
Arch Iran Med; 2023 Oct; 26(10):547-553. PubMed ID: 38310410
[TBL] [Abstract] [Full Text] [Related]
8. Cancer mortality in childhood and adolescence: analysis of trends and spatial distribution in the 133 intermediate Brazilian regions grouped by macroregions.
Velame KT; Antunes JLF
Rev Bras Epidemiol; 2024; 27():e240003. PubMed ID: 38294061
[TBL] [Abstract] [Full Text] [Related]
9. A system review of central nervous system tumors on children in China: epidemiology and clinical characteristics.
Yao B; Wang H; Wu X; Wang C; Tang T; An W; Zhu B
BMC Cancer; 2024 Jan; 24(1):138. PubMed ID: 38281032
[TBL] [Abstract] [Full Text] [Related]
10. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
[TBL] [Abstract] [Full Text] [Related]
11. Tissue-Predisposition to Cancer Driver Mutations.
Peters L; Venkatachalam A; Ben-Neriah Y
Cells; 2024 Jan; 13(2):. PubMed ID: 38247798
[TBL] [Abstract] [Full Text] [Related]
12. The burden of acute lymphoid leukemia among adolescents and young adults in the Western Pacific Region: evidence from Global Burden Disease 2019.
Yang F; Zhang B; Lodder P; Guo J
Cancer Causes Control; 2024 May; 35(5):839-848. PubMed ID: 38227176
[TBL] [Abstract] [Full Text] [Related]
13. Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India.
Singh N; Gupta A; Kumar S; Mawalankar G; Gupta B; Dhole N; Kori R; Singh A
J Hematop; 2023 Mar; 16(1):17-25. PubMed ID: 38175369
[TBL] [Abstract] [Full Text] [Related]
14. National and subnational burden of leukemia and its risk factors, 1990-2019: Results from the Global Burden of Disease study 2019.
Poopak A; Saeedi Moghaddam S; Esfahani Z; Keykhaei M; Rezaei N; Rezaei N; Rashidi MM; Ahmadi N; Abbasi-Kangevari M; Malekpour MR; Ghamari SH; Djalalinia S; Tavangar SM; Larijani B; Kompani F
PLoS One; 2023; 18(11):e0287917. PubMed ID: 38033110
[TBL] [Abstract] [Full Text] [Related]
15. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
16. Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancies: A Pharmacokinetic Study.
AbdelMagid AM; Abbassi MM; Ebeid FS; Farid SF; El-Sayed MH
Clin Ther; 2024 Jan; 46(1):e12-e22. PubMed ID: 37925363
[TBL] [Abstract] [Full Text] [Related]
17. Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy.
Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
Cancer Control; 2023; 30():10732748231202906. PubMed ID: 37877513
[TBL] [Abstract] [Full Text] [Related]
18. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
[TBL] [Abstract] [Full Text] [Related]
19. PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P; Baran N; Harutyunyan K; Cavazos A; Mallampati S; Chin RL; Jiang Z; Sun X; Lee HH; Hsu JL; Williams P; Huang X; Curran MA; Hung MC; Konopleva M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793852
[TBL] [Abstract] [Full Text] [Related]
20. Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
Zaninelli S; Meli C; Borleri G; Quaroni M; Pavoni C; Gaipa G; Biondi A; Introna M; Golay J; Rambaldi A; Rambaldi B
Cytometry A; 2024 Feb; 105(2):112-123. PubMed ID: 37707318
[TBL] [Abstract] [Full Text] [Related]
[Next]
